You are here:
Gavi’s two funding streams, innovative finance and direct contributions account for 25% and 75% respectively of the Vaccine Alliance’s overall funding portfolio.
Multi-year pledges and commitments are crucial to sustaining Gavi's ongoing programmes and its ability to fund new vaccines.
Public-private partnerships Corporations, private individuals & foundations play a vital role in meeting Gavi needs, accounting for 20% of 2000 to 2020 funding.
Cultivation of key public & private donor relationships, co-financing, shaping vaccine markets and mobilising civil society advocacy.
One woman dies from cervical cancer every two minutes - or 266,000 a year - over 85% in the developing world. Two-thirds of all cervical cancer deaths can be prevented with HPV vaccine.
25 April 2016
Vaccine development needs global alliance
26 February 2016
Zika and Ebola: A taste of things to come?
20 January 2016
Ebola: $5m vaccine deal announced
02 December 2015
Measles Outbreaks Are a Sign of Bigger Problems
03 March 2015
Ebola vaccine research in Africa
02 October 2013
Laos becomes first South East Asian nation to introduce pneumococcal vaccine
04 May 2013
Sojo Stories: Immunizing 250 Million Children By 2015
27 March 2013
Seth Berkley on Immunization in Pakistan
Heartfile eForum Blog
Concerned about the misuse of Gavi resources? Report it now.
© Gavi 2016
modal window here